Equities

Virios Therapeutics Inc

VIRI:NAQ

Virios Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.4695
  • Today's Change0.014 / 3.01%
  • Shares traded39.90k
  • 1 Year change-39.44%
  • Beta1.8694
Data delayed at least 15 minutes, as of Apr 26 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • VIRI:NAQ trading volume exceeds daily average by +17.64%
  • VIRI:NAQ price moved over +1.01% to 0.4399
  • VIRI:NAQ price falls below 50-day moving average to 0.401 at 16:30 BST
  • VIRI:NAQ price falls below 15-day moving average to 0.44 at 10:31 BST
  • VIRI:NAQ price rises above 15-day moving average to 0.4598 at 11:03 BST
  • VIRI:NAQ price rises above 15-day moving average to 0.469 at 12:24 BST

Key statistics

On Friday, Virios Therapeutics Inc (VIRI:NAQ) closed at 0.4695, 68.28% above the 52 week low of 0.279 set on Mar 05, 2024.
52-week range
Today
0.279Mar 05 20242.42Jul 14 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.4609
High0.4749
Low0.44
Bid0.4421
Offer0.4749
Previous close0.4558
Average volume107.09k
Shares outstanding19.26m
Free float17.39m
P/E (TTM)--
Market cap8.78m USD
EPS (TTM)-0.283
USD
Data delayed at least 15 minutes, as of Apr 26 2024 20:59 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.